Novo Nordisk is leveraging India's research capabilities to accelerate drug discovery for sickle cell disease, while partnering with the government to improve diagnosis and care for affected tribal…

Novo Nordisk is leveraging India's research capabilities to accelerate drug discovery for sickle cell disease, while partnering with the government to improve diagnosis and care for affected tribal communities through wellness hubs.

Source disclosure

This is a source-linked briefing. Read the original report from Asianet Newsable .